EQUITY RESEARCH MEMO

Orthoscan

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)45/100

Orthoscan is a privately held medical device company based in Scottsdale, Arizona, that develops and manufactures mobile C-arm imaging systems for orthopedic and surgical applications. Founded in 2004, the company specializes in mini and full-size C-arms designed to deliver high-quality, low-dose radiation imaging in clinical and surgical settings. Its product portfolio emphasizes portability and ease of use, positioning Orthoscan as a provider of point-of-care diagnostic imaging solutions that enable real-time visualization during procedures. The company's systems are utilized in hospitals, ambulatory surgery centers, and clinics, catering to the growing demand for cost-effective and versatile imaging equipment. Despite operating in a competitive market dominated by larger players such as GE Healthcare and Siemens Healthineers, Orthoscan differentiates itself through its focus on orthopedic-specific features and lower price points. The company's private status limits disclosure of financials, but its sustained presence since 2004 suggests a stable market niche. Near-term growth may be driven by increasing adoption of minimally invasive surgeries and outpatient procedures. However, challenges include the need for continuous innovation to keep pace with AI and dose-reduction advancements, as well as securing regulatory clearances for new products. Overall, Orthoscan represents a niche player with moderate growth potential if it can successfully differentiate and expand its customer base.

Upcoming Catalysts (preview)

  • Q4 2026FDA clearance for next-generation mini C-arm with AI-based dose optimization70% success
  • Q1 2027Launch of cloud-based remote imaging software platform for surgical guidance60% success
  • Q3 2026Strategic distribution partnership with a major orthopedic hospital network in the US65% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)